A.I. Virtanen Institute for Molecular Sciences - News

The Frontiers in Health Sciences seminar series will continue in October–December 2021 with online lectures by leading Finnish scientists. The lectures are open to all.

The Finnish coronavirus vaccine developer Rokote Laboratories Finland Ltd. has appointed Tuija Keinonen, Doctor of Science (Pharmacy), as the company's new CEO.

You, too, could be suffering from fatty liver – even if you don’t drink any alcohol. Often, weight gain causes fat to build up in the liver, but also genes, gut microbes, and even environmental chemicals play a role.

A new study provides a novel genetic tool to identify C9orf72 repeat expansion-carrying frontotemporal lobar degeneration or ALS patients from large population-based cohorts.

A recent experimental study shows how regular physical exercise modulates iron metabolism in both the brain and the muscles. The findings also help to better understand the benefits of exercise in Alzheimer’s disease.

A new study suggests that skin fibroblasts from frontotemporal dementia patients may be useful in investigating underlying disease mechanisms as well as in biomarker and drug research.

Using single cell technology, a new study sheds light on the significance of genetic risk factors for, and the diversity of cells involved in, the development of coronary artery disease.

Rokote Laboratories Finland Ltd. has secured total of nine million euros of funding for the development of a coronavirus vaccine to be administered as a nasal spray.

Kuopio will witness the building of a new, nationally unique laboratory environment where it is possible to process highly hazardous biological agents, such as coronaviruses.

Acute elevation in certain plasma microRNAs, along with downregulation of the clusterin protein within 2 days post-injury can act as early diagnostic and prognostic biomarkers for TBI, according to the doctoral dissertation of Shalini Das Gupta, MSc.